. "10"^^ . "Hrn\u010D\u00ED\u0159, Tom\u00E1\u0161" . . "Koz\u00E1kov\u00E1, Hana" . "9"^^ . "13"^^ . "Protective effect of Clostridium tyrobutyricum in acute dextran sodium sulphate-induced colitis: differential regulation of tumour necrosis factor-\u03B1 and interleukin-18 in BALB/c and severe combined immunodeficiency mice" . . . . . . . . "Protective effect of Clostridium tyrobutyricum in acute dextran sodium sulphate-induced colitis: differential regulation of tumour necrosis factor-\u03B1 and interleukin-18 in BALB/c and severe combined immunodeficiency mice"@en . "163050" . "Hudcovic, Tom\u00E1\u0161" . . "RIV/61388971:_____/12:00377981!RIV13-GA0-61388971" . . "\u0160r\u016Ftkov\u00E1, Dagmar" . "Wells, J. M." . . "167" . . "Protective effect of Clostridium tyrobutyricum in acute dextran sodium sulphate-induced colitis: differential regulation of tumour necrosis factor-\u03B1 and interleukin-18 in BALB/c and severe combined immunodeficiency mice" . "Clinical and Experimental Immunology" . "Du, Zhengyu" . . . "\u0160t\u011Bp\u00E1nkov\u00E1, Renata" . . . "[3A83C4BC4060]" . . "Kol\u00EDnsk\u00E1, Ji\u0159ina" . "Protective effect of Clostridium tyrobutyricum in acute dextran sodium sulphate-induced colitis: differential regulation of tumour necrosis factor-\u03B1 and interleukin-18 in BALB/c and severe combined immunodeficiency mice"@en . "Tlaskalov\u00E1-Hogenov\u00E1, Helena" . . . . "One of the promising approaches in the therapy of ulcerative colitis is administration of butyrate, an energy source for colonocytes, into the lumen of the colon. This study investigates the effect of butyrate producing bakterium Clostridium tyrobutyricum on dextran sodium sulphate (DSS)-induced colitis in mice. Immunocompetent BALB/c and immunodeficient severe combined immunodeficiency (SCID) mice reared in specific-pathogen-free (SPF) conditions were treated intrarectally with C. tyrobutyricum 1 week prior to the induction of DSS colitis and during oral DSS treatment. Administration of DSS without C. tyrobutyricum treatment led to an appearance of clinical symptoms \u2013 bleeding, rectal prolapses and colitis-induced increase in the antigen CD11b, a marker of infiltrating inflammatory cells in the lamina propria"@en . . "RIV/61388971:_____/12:00377981" . "Klepet\u00E1\u0159, Jan" . "000299037700021" . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . . "P(2B06155), P(GA303/08/0367), P(GA303/09/0449), P(GAP304/11/1252), P(ME10017), Z(AV0Z50110509), Z(AV0Z50200510)" . "Du, Zhengyu" . . "One of the promising approaches in the therapy of ulcerative colitis is administration of butyrate, an energy source for colonocytes, into the lumen of the colon. This study investigates the effect of butyrate producing bakterium Clostridium tyrobutyricum on dextran sodium sulphate (DSS)-induced colitis in mice. Immunocompetent BALB/c and immunodeficient severe combined immunodeficiency (SCID) mice reared in specific-pathogen-free (SPF) conditions were treated intrarectally with C. tyrobutyricum 1 week prior to the induction of DSS colitis and during oral DSS treatment. Administration of DSS without C. tyrobutyricum treatment led to an appearance of clinical symptoms \u2013 bleeding, rectal prolapses and colitis-induced increase in the antigen CD11b, a marker of infiltrating inflammatory cells in the lamina propria" . "Schwarzer, Martin" . "2" . "butyrate; Clostridium tyrobutyricum; confocal fluorimetry"@en . "\u0158ezanka, Tom\u00E1\u0161" . . . "10.1111/j.1365-2249.2011.04498.x" . "0009-9104" . . "Erban, V." . . . .